Loading memory…
Loading memory…
Patent portfolio assigned to Altay Therapeutics (verified via public assignee records). Biotech developing small-molecule inhibitors of 'undruggable' transcription factors (DUX4, STAT3); San Carlos CA, YC. Patents confirmed: BioWorld patent-tracking reports Altay Therapeutics Inc. disclosed STAT3 inhibitors; USPTO doc 12043640 'Prodrugs of STAT3 inhibitors' (intl filing June 2023). Exact assigned count not enumerated (Google Patents search 503); estimate left 0.